Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Implications for a Deeper Clinical Understanding of Moyamoya Disease: Temporal Evolution of Suzuki Staging.

Neurosurgery practice·2026
Same author

Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.

Acta neuropathologica·2026
Same author

Ultrasound modulates microglial activity and reduces neuroinflammation in a parameter-dependent manner.

NPJ acoustics·2026
Same author

Cytokine Profiling of Systemic Sclerosis-Related Pulmonary Hypertension.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Author Correction: UK Biobank at 20 - a growing, global resource for dementia research.

Nature reviews. Neurology·2026
Same author

The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Stanley Williams1, Samrah Siddiqi1, Sulin Liu1

  • 1UK Dementia Research Institute at Imperial College, LONDON, London, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

突触损失是阿尔茨海默病 (AD) 的关键. 聚乙烯追踪器UCB-J针对SV2a,但SV2a不仅在突触上,限制了其作为AD突触密度生物标志物的使用.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 神经病理学神经病理学
  • 生物标志物开发 生物标志物开发

背景情况:

  • 突触损失是阿尔茨海默病 (AD) 的标志,与认知能力下降相关.
  • PET 标记器 UCB-J 准 SV2a,一种被认为标记突触密度的蛋白质.
  • 在突触外SV2a的存在使其作为可靠的AD生物标志物的解释变得复杂.

研究的目的:

  • 为了研究SV2a.的细胞和亚细胞分布.
  • 为了澄清大脑中SV2a的PET信号的来源.
  • 评估SV2a作为阿尔茨海默病中突触密度生物标志物的实用性.

主要方法:

  • 来自AD和对照对象的人类死后脑组织被染色为SV2a和各种突触和非突触标记物.
  • 对焦成像和Imaris软件用于详细的细胞和亚细胞分析.
  • 进行了局部化分析,以确定SV2a.的突触和非突触分布.

主要成果:

  • SV2a与突触标记物 (synaptophysin,VGLUT1,VGAT) 显示了部分局部化,表明它不在所有突触中存在.
  • 在非突触神经元区 (轴突,体部区域) 和质细胞,特别是星球细胞中发现了显著比例的SV2a.
  • 与对照人群相比,在AD皮质组织中,星体细胞中的SV2a水平升高.

结论:

  • SV2a不仅局限于突触,主要表达在神经元和质区.
  • SV2a的非突触分布表明,针对SV2a的PET标记物可能不会准确地反映阿尔茨海默病中的真实突触密度.
  • 作为AD中突触损失的直接生物标志物,SV2a的实用性需要重新评估.